Microbot Medical Inc. announces a direct offering of common stock and a concurrent private placement, raising approximately $13 million. Microbot Medical Inc. announced a registered direct offering ...
Lyra Therapeutics, Inc. has announced a definitive agreement to sell 423,372 shares of common stock and associated private placement warrants through a registered direct offering priced at $11.81 per ...
LEXINGTON, Mass., July 2, 2025 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW) announced today that pursuant to warrant exercise agreements dated Aug. 2, 2024, three existing accredited investors ...
CAPE CANAVERAL, Fla.--(BUSINESS WIRE)--Sidus Space, Inc. (“Sidus” or the “Company”) (NASDAQ:SIDU), a multi-faceted Space and Data-as-a-Service company, today announced that it has entered into a ...
RAANANA, ISRAEL, April 07, 2026 (GLOBE NEWSWIRE)-- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced ...
CAESAREA, Israel, March 26, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...
In a concurrent private placement, the Company also agreed to sell to the same investor, investor warrants (the “PIPE Common Warrants”). Aggregate gross proceeds to the Company from both transactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results